# Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

> **NCT06381648** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 230 (actual)

## Conditions studied

- Cholangiocarcinoma
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinoma Resectable
- Cholangiocarcinoma; Liver

## Interventions

- **DIAGNOSTIC_TEST:** LyMIC (Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma)

## Key facts

- **NCT ID:** NCT06381648
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-15
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06381648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06381648, "Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06381648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*